Although it remains unclear whether glucocorticoid therapy affects the expression of PD-1/PD-L1 in immune cells in MS, we propose that glucocorticoid therapy may exert an immunosuppressive effect by increasing the expression of PD-1 on immune cells. Here, PDCD1 is linked to myeloid sarcoma.